Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Eva-Maria Wagner-Drouet"'
Autor:
Johannes Schetelig, Henning Baldauf, Falk Heidenreich, Jorinde D. Hoogenboom, Stephen R. Spellman, Alexander Kulagin, Thomas Schroeder, Henrik Sengeloev, Peter Dreger, Edouard Forcade, Jan Vydra, Eva Maria Wagner-Drouet, Goda Choi, Shankara Paneesha, Nuno A. A. Miranda, Alina Tanase, Liesbeth C. de Wreede, Vinzenz Lange, Alexander H. Schmidt, Jürgen Sauter, Joshua A. Fein, Yung-Tsi Bolon, Meilun He, Steven G. E. Marsh, Shahinaz M. Gadalla, Sophie Paczesny, Annalisa Ruggeri, Christian Chabannon, Katharina Fleischhauer
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Optimizing natural killer (NK) cell alloreactivity could further improve outcome after allogeneic hematopoietic cell transplantation (alloHCT). The donor’s Killer-cell Immunoglobulin-like Receptor (KIR) genotype may provide important information in
Externí odkaz:
https://doaj.org/article/2b878953d63c4541a7adf722c396e6d2
Autor:
Raffaella Greco, Jorinde D. Hoogenboom, Edouard F. Bonneville, Achilles Anagnostopoulos, Angela Cuoghi, Jean-Hugues Dalle, Eva M. Weissinger, Peter Lang, Federica Galaverna, Massimo Martino, Alexei Maschan, Christine Mauz-Körholz, Maddalena Noviello, Jakob Passweg, Jacopo Peccatori, Montserrat Rovira, Carlos Solano, Hendrik Veelken, Andrea Velardi, Eva Maria Wagner-Drouet, Xi Zhang, Fabio Ciceri, Chiara Bonini, Luca Vago, Annalisa Ruggeri, Christian Chabannon
Publikováno v:
Bone Marrow Transplantation. 58:603-606
Autor:
Andreas Kreft, Katrin Hippe, Eva Maria Wagner-Drouet, Isabelle Ries, Arne Kandulski, Maike Büttner-Herold, Helmut Neumann, Daniela Weber, Ernst Holler, Mario Schindeldecker
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0256543 (2021)
Acute graft versus host disease (aGvHD) is an important, life-threatening complication after allogeneic hematopoietic stem cell transplantation (alloHSCT). To investigate the value of multiple simultaneous colon biopsies in improving diagnostic accur
Externí odkaz:
https://doaj.org/article/2bcd643cba4041b1992eac8e398af278
Autor:
Jürgen Finke, Claudia Schmoor, Matthias Stelljes, Andreas Burchert, Peter Dreger, Ute Hegenbart, Eva-Maria Wagner-Drouet, Martin Bornhäuser, Kristina Sohlbach, Natalie Schub, Christian Reicherts, Guido Kobbe, Bertram Glass, Hartmut Bertz, Olga Grishina
Publikováno v:
Bone Marrow Transplantation. 57:1664-1670
Therapeutic options for patients with AML relapsing after allogeneic HCT range from chemotherapy or hypomethylating agents with or without donor lymphocyte infusions to a 2nd allogeneic HCT. Available data are based on retrospective single center or
Autor:
Eva Maria Wagner-Drouet, Pascal Woelfinger, Wilfried Wagner, Oliver Kriege, Matthias Theobald, Andreas Schwarting, Frank Birklein, Julia Heider, Beate Hauptrock
Publikováno v:
Transplantation Proceedings. 53:1365-1368
A 53-year-old female patient with acute myeloid leukemia developed severe chronic graft vs host disease (cGVHD) of the oral mucosa after allogeneic hematopoietic stem cell transplantation with leukoplakia and relapsing oral squamous cell carcinoma (S
Autor:
M Middeke, A Simon, Anita Lawitschka, A Baumgartner, P Jäger, Jörg Halter, Daniel Wolff, Jann Arends, Hildegard T. Greinix, Gesine Bug, Silvan Klein, R Toenges, Christoph Schmid, I Hilgendorf, Eva-Maria Wagner-Drouet
Publikováno v:
Clinical Nutrition. 40:1571-1577
Summary Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is frequently associated with impaired oral intake and malnutrition, which potentially increases morbidity and mortality. Therefore, nutrition is one of the major challe
Autor:
Arjan A. Van de Loosdrecht, Jacqueline Cloos, Eva-Maria Wagner-Drouet, Uwe Platzbecker, Tobias A.W. Holderried, Catharina van Elssen, Aristoteles Giagounidis, Marij J.P. Welters, Sjoerd H. van der Burg, Hester J.T. van Zeeburg, Jeroen Rovers, Bjorn T. Gjertsen
Publikováno v:
Blood. 140:3410-3411
Autor:
Arjan A. Van de Loosdrecht, Jacqueline Cloos, Eva-Maria Wagner-Drouet, Uwe Platzbecker, Tobias A.W. Holderried, Catharina van Elssen, Aristoteles Giagounidis, Sören Lehmann, Hester J.T. van Zeeburg, Jeroen Rovers, Bjorn T. Gjertsen
Publikováno v:
Blood. 140:1714-1715
Autor:
Friedrich Stolzl, S. von Harsdorf, Irina Türüchanow, Karin Westphal, Arnold Ganser, Donald Bunjes, Michael Stadler, Gernot Beutel, Armin Papkalla, Danny Jonigk, Steve Ehrlich, Diethelm Messinger, Lothar Hambach, Johannes Schetelig, Heiko von der Leyen, Hans Kreipe, Stefan Klein, Wolfgang Bethge, Iyas Hamwi, Eva M. Weissinger, Eva-Maria Wagner-Drouet, Julia Raad, Jürgen Krauter, Michael Schleuning, Ernst Holler, Herrad Baurmann, Andreas Rank, Jochen Metzger, Christoph Schmid, Daniela Heidenreich, Kerstin Schäfer-Eckart
Publikováno v:
Leukemia
Acute graft-versus-host disease (aGvHD) contributes to about 50% of transplant-related mortality (non-relapse mortality) after allogeneic hematopoietic stem cell transplantation (HSCT). Here the predictive value of a urinary proteomic profile (aGvHD_
Autor:
Elke Rücker-Braun, Rainer Ordemann, H. Schmidt, Martin Bornhäuser, Laszlo Gopsca, Gerhard Ehninger, Frank Kroschinsky, Tigran Torosian, Michael Kramer, Raphael Teipel, Matthias Blechschmidt, Kristina Hölig, Kristin Zimmer, Eva Maria Wagner-Drouet, Uta Oelschlaegel, Johannes Schetelig, Falk Heidenreich, Katharina Heidrich, Gero Hütter, Alexander H. Schmidt
Publikováno v:
Bone Marrow Transplantation
We conducted a prospective clinical trial to investigate the safety and efficacy of plerixafor (P) in allogeneic peripheral blood stem cells (PBSC) donors with poor mobilization response to standard-dose granulocyte colony-stimulating factor (G-CSF),